T1	AdverseReaction 54 69	Splenic Rupture
T2	AdverseReaction 120 155	Acute Respiratory Distress Syndrome
T3	AdverseReaction 157 161	ARDS
T4	AdverseReaction 249 267	Allergic reactions
T5	AdverseReaction 269 288	angioneurotic edema
T6	AdverseReaction 290 309	dermatitis allergic
T7	AdverseReaction 311 332	drug hypersensitivity
T8	AdverseReaction 334 350	hypersensitivity
T9	AdverseReaction 352 356	rash
T10	AdverseReaction 358 371	pruritic rash
T11	AdverseReaction 376 385	urticaria
T12	AdverseReaction 404 422	Sickle cell crisis
T13	AdverseReaction 445 450	fatal
T14	Severity 424 430	Severe
T15	AdverseReaction 518 541	Capillary Leak Syndrome
T16	AdverseReaction 660 675	Splenic rupture
T17	AdverseReaction 687 692	fatal
T18	Factor 700 703	can
T19	AdverseReaction 998 1033	Acute respiratory distress syndrome
T20	AdverseReaction 1035 1039	ARDS
T22	DrugClass 1073 1117	human granulocyte colony-stimulating factors
T23	AdverseReaction 1319 1337	allergic reactions
T24	Severity 1311 1318	Serious
T25	AdverseReaction 1348 1359	anaphylaxis
T27	DrugClass 1392 1436	human granulocyte colony-stimulating factors
T28	AdverseReaction 1873 1878	fatal
T29	AdverseReaction 1879 1897	sickle cell crises
T30	AdverseReaction 2261 2284	Capillary leak syndrome
T31	AdverseReaction 2286 2289	CLS
T32	AdverseReaction 2392 2403	hypotension
T33	AdverseReaction 2405 2420	hypoalbuminemia
T34	AdverseReaction 2422 2427	edema
T35	AdverseReaction 2432 2449	hemoconcentration
T36	DrugClass 2323 2367	human granulocyte colony-stimulating factors
T39	AdverseReaction 2956 2973;2978 2983	growth factor for tumor
T40	AdverseReaction 3000 3020	myeloid malignancies
T41	AdverseReaction 3025 3039	myelodysplasia
T42	Factor 2922 2933	possibility
T37	Factor 458 461	can
T38	Factor 1898 1901	can
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E10	AdverseReaction:T10
E11	AdverseReaction:T11
E12	AdverseReaction:T12 Effect:E14 Hypothetical:E37
E13	AdverseReaction:T13 Hypothetical:E37
E14	Severity:T14
E15	AdverseReaction:T15
E16	AdverseReaction:T16 Hypothetical:E18
E17	AdverseReaction:T17 Hypothetical:E18
E18	Factor:T18
E19	AdverseReaction:T19 Hypothetical2:E22
E20	AdverseReaction:T20 Hypothetical2:E22
E22	DrugClass:T22
E23	AdverseReaction:T23 Effect:E24 Hypothetical:E27
E24	Severity:T24
E25	AdverseReaction:T25 Hypothetical:E27
E27	DrugClass:T27
E28	AdverseReaction:T28 Hypothetical:E38
E29	AdverseReaction:T29 Hypothetical:E38
E30	AdverseReaction:T30 Hypothetical:E36
E31	AdverseReaction:T31 Hypothetical:E36
E32	AdverseReaction:T32
E33	AdverseReaction:T33
E34	AdverseReaction:T34
E35	AdverseReaction:T35
E36	DrugClass:T36
E39	AdverseReaction:T39 Hypothetical:E42
E40	AdverseReaction:T40 Hypothetical:E42
E41	AdverseReaction:T41 Hypothetical:E42
E42	Factor:T42
E37	Factor:T37
E38	Factor:T38
A1	CUI E1 C0038000
A2	UMLS-Preferred-Name E1 Splenic Rupture
A3	MEDDRA-PT E1 Splenic rupture
A4	MEDDRA-PT-ID E1 10041658
A5	CUI E2 C0035222
A6	UMLS-Preferred-Name E2 Respiratory Distress Syndrome, Adult
A7	MEDDRA-PT E2 Acute respiratory distress syndrome
A8	MEDDRA-PT-ID E2 10001052
A9	CUI E3 C0035222
A10	UMLS-Preferred-Name E3 Respiratory Distress Syndrome, Adult
A11	MEDDRA-PT E3 Acute respiratory distress syndrome
A12	MEDDRA-PT-ID E3 10001052
A13	LLT E3 ARDS
A14	LLT-ID E3 10003083
A15	CUI E4 C1527304
A16	UMLS-Preferred-Name E4 Allergic Reaction
A17	MEDDRA-PT E4 Hypersensitivity
A18	MEDDRA-PT-ID E4 10020751
A19	LLT E4 Allergic reaction
A20	LLT-ID E4 10001718
A21	CUI E5 C0002994
A22	UMLS-Preferred-Name E5 Angioedema
A23	MEDDRA-PT E5 Angioedema
A24	MEDDRA-PT-ID E5 10002424
A25	LLT E5 Angioneurotic edema
A26	LLT-ID E5 10002471
A27	CUI E6 C0011615
A28	UMLS-Preferred-Name E6 Dermatitis, Atopic
A29	MEDDRA-PT E6 Dermatitis allergic
A30	MEDDRA-PT-ID E6 10012434
A31	CUI E7 C0013182
A32	UMLS-Preferred-Name E7 Drug Allergy
A33	MEDDRA-PT E7 Drug hypersensitivity
A34	MEDDRA-PT-ID E7 10013700
A35	CUI E8 C0020517
A36	UMLS-Preferred-Name E8 Hypersensitivity
A37	MEDDRA-PT E8 Hypersensitivity
A38	MEDDRA-PT-ID E8 10020751
A39	CUI E9 C0015230
A40	UMLS-Preferred-Name E9 Exanthema
A41	MEDDRA-PT E9 Rash
A42	MEDDRA-PT-ID E9 10037844
A43	CUI E10 C0033771
A44	UMLS-Preferred-Name E10 Prurigo
A45	MEDDRA-PT E10 Rash pruritic
A46	MEDDRA-PT-ID E10 10037884
A47	LLT E10 Pruritic rash
A48	LLT-ID E10 10037085
A49	CUI E11 C0042109
A50	UMLS-Preferred-Name E11 Urticaria
A51	MEDDRA-PT E11 Urticaria
A52	MEDDRA-PT-ID E11 10046735
A53	CUI E12 C0238425
A54	UMLS-Preferred-Name E12 Hemoglobin SS disease with crisis
A55	MEDDRA-PT E12 Sickle cell anaemia with crisis
A56	MEDDRA-PT-ID E12 10040642
A57	LLT E12 Sickle cell crisis
A58	LLT-ID E12 10040643
A59	CUI E13 C1306577
A60	UMLS-Preferred-Name E13 Death (finding)
A61	MEDDRA-PT E13 Death
A62	MEDDRA-PT-ID E13 10011906
A63	CUI E15 C0343084
A64	UMLS-Preferred-Name E15 Capillary Leak Syndrome
A65	MEDDRA-PT E15 Capillary leak syndrome
A66	MEDDRA-PT-ID E15 10007196
A67	CUI E16 C0038000
A68	UMLS-Preferred-Name E16 Splenic Rupture
A69	MEDDRA-PT E16 Splenic rupture
A70	MEDDRA-PT-ID E16 10041658
A71	CUI E17 C1306577
A72	UMLS-Preferred-Name E17 Death (finding)
A73	MEDDRA-PT E17 Death
A74	MEDDRA-PT-ID E17 10011906
A75	CUI E19 C0035222
A76	UMLS-Preferred-Name E19 Respiratory Distress Syndrome, Adult
A77	MEDDRA-PT E19 Acute respiratory distress syndrome
A78	MEDDRA-PT-ID E19 10001052
A79	CUI E20 C0035222
A80	UMLS-Preferred-Name E20 Respiratory Distress Syndrome, Adult
A81	MEDDRA-PT E20 Acute respiratory distress syndrome
A82	MEDDRA-PT-ID E20 10001052
A83	LLT E20 ARDS
A84	LLT-ID E20 10003083
A85	CUI E23 C1527304
A86	UMLS-Preferred-Name E23 Allergic Reaction
A87	MEDDRA-PT E23 Hypersensitivity
A88	MEDDRA-PT-ID E23 10020751
A89	LLT E23 Allergic reaction
A90	LLT-ID E23 10001718
A91	CUI E25 C0002792
A92	UMLS-Preferred-Name E25 anaphylaxis
A93	MEDDRA-PT E25 Anaphylactic reaction
A94	MEDDRA-PT-ID E25 10002198
A95	LLT E25 Anaphylaxis
A96	LLT-ID E25 10002218
A97	CUI E28 C1306577
A98	UMLS-Preferred-Name E28 Death (finding)
A99	MEDDRA-PT E28 Death
A100	MEDDRA-PT-ID E28 10011906
A101	CUI E29 C0238425
A102	UMLS-Preferred-Name E29 Hemoglobin SS disease with crisis
A103	MEDDRA-PT E29 Sickle cell anaemia with crisis
A104	MEDDRA-PT-ID E29 10040642
A105	LLT E29 Sickle cell crisis
A106	LLT-ID E29 10040643
A107	CUI E30 C0343084
A108	UMLS-Preferred-Name E30 Capillary Leak Syndrome
A109	MEDDRA-PT E30 Capillary leak syndrome
A110	MEDDRA-PT-ID E30 10007196
A111	CUI E31 C0343084
A112	UMLS-Preferred-Name E31 Capillary Leak Syndrome
A113	MEDDRA-PT E31 Capillary leak syndrome
A114	MEDDRA-PT-ID E31 10007196
A115	CUI E32 C0020649
A116	UMLS-Preferred-Name E32 Hypotension
A117	MEDDRA-PT E32 Hypotension
A118	MEDDRA-PT-ID E32 10021097
A119	CUI E33 C0239981
A120	UMLS-Preferred-Name E33 Hypoalbuminemia
A121	MEDDRA-PT E33 Hypoalbuminaemia
A122	MEDDRA-PT-ID E33 10020942
A123	LLT E33 Hypoalbuminemia
A124	LLT-ID E33 10020943
A125	CUI E34 C0013604
A126	UMLS-Preferred-Name E34 Edema
A127	MEDDRA-PT E34 Oedema
A128	MEDDRA-PT-ID E34 10030095
A129	LLT E34 Edema
A130	LLT-ID E34 10014210
A131	CUI E35 C0854379
A132	UMLS-Preferred-Name E35 Haemoconcentration
A133	MEDDRA-PT E35 Haemoconcentration
A134	MEDDRA-PT-ID E35 10018873
A135	LLT E35 Hemoconcentration
A136	LLT-ID E35 10019479
A137	CUI E39 C0549387
A138	UMLS-Preferred-Name E39 Neoplasm growth accelerated
A139	MEDDRA-PT E39 Neoplasm
A140	MEDDRA-PT-ID E39 10028980
A141	LLT E39 Neoplasm growth accelerated
A142	LLT-ID E39 10028994
A143	CUI E40 C2939461
A144	UMLS-Preferred-Name E40 Myeloid neoplasm
A145	MEDDRA-PT E40 Myeloid metaplasia
A146	MEDDRA-PT-ID E40 10028561
A147	CUI E41 C0026985
A148	UMLS-Preferred-Name E41 Myelodysplasia
A149	MEDDRA-PT E41 Myelodysplastic syndrome
A150	MEDDRA-PT-ID E41 10028533
A151	LLT E41 Myelodysplasia
A152	LLT-ID E41 10028532
